These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 25294056)
1. Clinical outcomes of persistent and paroxysmal atrial fibrillation in patients with stroke. Deguchi I; Fukuoka T; Hayashi T; Maruyama H; Sehara Y; Kato Y; Horiuchi Y; Nagamine Y; Sano H; Tanahashi N J Stroke Cerebrovasc Dis; 2014; 23(10):2840-2844. PubMed ID: 25294056 [TBL] [Abstract][Full Text] [Related]
2. Features of cardioembolic stroke with persistent and paroxysmal atrial fibrillation - a study with the Japan Stroke Registry. Deguchi I; Hayashi T; Fukuoka T; Kobayashi S; Tanahashi N; Eur J Neurol; 2015 Aug; 22(8):1215-9. PubMed ID: 25962447 [TBL] [Abstract][Full Text] [Related]
3. Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation. Deguchi I; Ogawa H; Ohe Y; Nemoto M; Tanahashi N J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):846-50. PubMed ID: 22819543 [TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation type matters: greater infarct volume and worse neurological defects seen in acute cardiogenic cerebral embolism due to persistent or permanent rather than paroxysmal atrial fibrillation. Inaba O; Yamauchi Y; Sekigawa M; Miwa N; Yamaguchi J; Nagata Y; Obayashi T; Miyamoto T; Kamata T; Isobe M; Goya M; Hirao K Europace; 2018 Oct; 20(10):1591-1597. PubMed ID: 29244081 [TBL] [Abstract][Full Text] [Related]
5. CHADS2 score/CHA2 DS2 -VASc score and major artery occlusion in cardioembolic stroke patients with nonvalvular atrial fibrillation. Deguchi I; Hayashi T; Ohe Y; Kato Y; Fukuoka T; Maruyama H; Horiuchi Y; Sano H; Nagamine Y; Tanahashi N Int J Stroke; 2014 Jul; 9(5):576-9. PubMed ID: 24447527 [TBL] [Abstract][Full Text] [Related]
6. Low Body Mass Index is a Poor Prognosis Factor in Cardioembolic Stroke Patients with NonValvular Atrial Fibrillation. Hagii J; Metoki N; Saito S; Fujita A; Shiroto H; Sasaki S; Takahashi K; Hitomi H; Baba Y; Seino S; Kamada T; Uchizawa T; Iwata M; Matsumoto S; Yasujima M; Tomita H J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3155-3162. PubMed ID: 30093200 [TBL] [Abstract][Full Text] [Related]
7. Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation. Matsumoto M; Sakaguchi M; Okazaki S; Furukado S; Tagaya M; Etani H; Shimazu T; Yoshimine T; Mochizuki H; Kitagawa K Cerebrovasc Dis; 2013; 35(1):64-72. PubMed ID: 23428999 [TBL] [Abstract][Full Text] [Related]
8. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation . Maruyama K; Uchiyama S; Shiga T; Iijima M; Ishizuka K; Hoshino T; Kitagawa K Cerebrovasc Dis Extra; 2017; 7(1):35-43. PubMed ID: 28253498 [TBL] [Abstract][Full Text] [Related]
9. Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry. Takabayashi K; Hamatani Y; Yamashita Y; Takagi D; Unoki T; Ishii M; Iguchi M; Masunaga N; Ogawa H; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GY; Akao M Stroke; 2015 Dec; 46(12):3354-61. PubMed ID: 26514188 [TBL] [Abstract][Full Text] [Related]
10. The CHA(2)DS(2)-VASc score reflects clinical outcomes in nonvalvular atrial fibrillation patients with an initial cardioembolic stroke. Deguchi I; Hayashi T; Ohe Y; Kato Y; Nagoya H; Fukuoka T; Maruyama H; Horiuchi Y; Tanahashi N J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e343-6. PubMed ID: 23523201 [TBL] [Abstract][Full Text] [Related]
11. Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation. Hagii J; Metoki N; Saito S; Shiroto H; Sasaki S; Takahashi K; Hitomi H; Baba Y; Yamada N; Seino S; Kamada T; Uchizawa T; Nakamura T; Yasujima M; Tomita H Thromb J; 2021 Mar; 19(1):22. PubMed ID: 33789684 [TBL] [Abstract][Full Text] [Related]
12. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation. Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M; Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of atrial fibrillation-related cardioembolic stroke in patients aged 80 years or older. Tanaka K; Yamada T; Torii T; Matsumoto S; Yoshimura T; Takase KI; Wakata Y; Nakashima N; Kira JI; Murai H Geriatr Gerontol Int; 2017 May; 17(5):708-713. PubMed ID: 27255203 [TBL] [Abstract][Full Text] [Related]
14. Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry. Esato M; Chun YH; An Y; Ogawa H; Wada H; Hasegawa K; Tsuji H; Abe M; Lip GYH; Akao M Chest; 2017 Dec; 152(6):1266-1275. PubMed ID: 28823813 [TBL] [Abstract][Full Text] [Related]
15. Effect of direct oral anticoagulant for acute major cerebral artery occlusion in cardioembolic stroke/transient ischemic attack patients with non-valvular atrial fibrillation. Tomari S; Arima J; Yoshida T; Yamashita H; Sata R; Hamada R; Kanda N; Takashima H J Neurol Sci; 2019 Jul; 402():162-166. PubMed ID: 31152970 [TBL] [Abstract][Full Text] [Related]
16. Ischemic lacunar stroke in patients with and without potential mechanism other than small-artery disease. Baumgartner RW; Sidler C; Mosso M; Georgiadis D Stroke; 2003 Mar; 34(3):653-9. PubMed ID: 12624287 [TBL] [Abstract][Full Text] [Related]
17. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation. Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940 [TBL] [Abstract][Full Text] [Related]
18. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898 [TBL] [Abstract][Full Text] [Related]
19. Predictors of Left Atrial Thrombi and Spontaneous Echocardiographic Contrast in the Acute Phase After Cardioembolic Stroke in Patients With Atrial Fibrillation. Kishima H; Mine T; Fukuhara E; Ashida K; Uchida K; Yoshimura S; Ishihara M J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1571-1577. PubMed ID: 30930240 [TBL] [Abstract][Full Text] [Related]
20. Preceding Antithrombotic Treatment is Associated With Acute Ischemic Stroke Severity and Functional Outcome at 90 Days Among Patients With Atrial Fibrillation. Yi X; Lin J; Han Z; Luo H; Shao M; Fan D; Zhou Q J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):2003-2010. PubMed ID: 31047821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]